Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjuvant proton beam therapy in patients with grade 2 meningiomas.

Surgical neurology international·2024
Same author

Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trial.

Cancer·2023
Same author

Harnessing the abscopal effect for gastrointestinal malignancies in the era of immunotherapy.

Journal of gastrointestinal oncology·2023
Same author

Image-Guided Proton Therapy: A Comprehensive Review.

Cancers·2023
Same author

Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials.

JAMA network open·2023
Same author

Perianal basosquamous carcinoma treated with radiation therapy, a case report.

Journal of gastrointestinal oncology·2023

Related Experiment Video

Updated: May 14, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Proton therapy for hepatocellular carcinoma.

Ted C Ling1, Joseph I Kang, David A Bush

  • 1Department of Radiation Medicine, Loma Linda University Medical Center, CA 92354, USA.

Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|January 30, 2013
PubMed
Summary

Proton radiotherapy offers improved tumor control for hepatocellular carcinoma (HCC) by delivering higher radiation doses while sparing healthy liver tissue. This advanced treatment minimizes toxicity compared to traditional methods, enhancing patient outcomes.

Keywords:
Proton radiotherapyhepatocellular carcinoma (HCC)

More Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

Related Experiment Videos

Last Updated: May 14, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

Area of Science:

  • Oncology
  • Radiation Oncology
  • Hepatobiliary Malignancies

Background:

  • Hepatocellular carcinoma (HCC) treatment traditionally faced limitations with external beam radiotherapy due to normal tissue toxicity.
  • Photon radiotherapy advancements improved dose conformity but still irradiated significant portions of healthy liver tissue.
  • Maximizing radiation dose to the tumor is crucial for improving HCC treatment outcomes.

Purpose of the Study:

  • To review the physical attributes and rationale for using proton radiotherapy in HCC treatment.
  • To examine the clinical outcomes of proton radiotherapy for HCC based on recent literature.

Main Methods:

  • Review of the physical characteristics of proton beams, focusing on their dose distribution properties.
  • Analysis of existing literature on the application and clinical efficacy of proton radiotherapy in HCC.
  • Comparison of proton radiotherapy with conventional photon radiotherapy in terms of dose delivery and normal tissue sparing.

Main Results:

  • Proton beams exhibit a finite range and no exit dose, allowing for precise radiation delivery to the tumor.
  • This physical property enables dose escalation to the HCC tumor while significantly reducing radiation exposure to surrounding healthy liver.
  • Emerging literature suggests favorable clinical outcomes and improved biological effectiveness with proton radiotherapy for HCC.

Conclusions:

  • Proton radiotherapy presents a superior physical advantage for HCC treatment due to its inherent dose distribution characteristics.
  • It facilitates dose escalation for enhanced tumor control and improved biological effectiveness by minimizing irradiated normal liver volume.
  • Proton radiotherapy is a promising modality for HCC, warranting further investigation and clinical adoption.